• PUFA-PL Biosynthesis Enzymes Drive Pathogenicity in Rice Bla

  2026-07-17

  This study reveals that fatty acid desaturase (Fad2) and acyl-CoA synthetase (Acsl4) are essential for the biosynthesis of polyunsaturated fatty acid-containing phospholipids (PUFA-PLs) in Magnaporthe oryzae. Their activity governs ferroptotic cell death, which is critical for fungal pathogenicity, highlighting new potential targets for crop protection strategies.

• NHE1 in Macrophages Drives Octanal/Olfr2-Induced Atheroscler

  2026-07-16

  This study uncovers how sodium-hydrogen exchanger 1 (NHE1) in macrophages is a crucial mediator of octanal/Olfr2-induced atherosclerosis, acting through calcium-dependent ROS and NLRP3 inflammasome activation. These mechanistic insights highlight NHE1 as a potential therapeutic target for modulating inflammation in cardiovascular disease.

• Linoleic Acid–PPARα–TF Axis Drives Tumor Progression in pLEL

  2026-07-16

  This study uncovers how linoleic acid promotes tumor progression in primary pulmonary lymphoepithelioma-like carcinoma (pLELC) by upregulating tissue factor (TF) expression through PPAR-α signaling. The research leverages multiomics, patient-derived models, and mechanistic analysis, highlighting new therapeutic targets for metabolic disorder and tumor microenvironment research.

• Rhodamine 123 (chloride): Advanced Workflows for Efflux Pump

  2026-07-15

  Rhodamine 123 (chloride) is a high-sensitivity tool for real-time analysis of membrane transporter function, especially in multidrug resistance research. This guide distills leading-edge workflows, troubleshooting strategies, and key reference findings to empower robust, translational P-glycoprotein efflux pump assays.

• CARD8 Inflammasome-Driven Pyroptosis in Human T Cells via DP

  2026-07-15

  A landmark study demonstrates that inhibiting dipeptidyl-peptidases with PT-100 (Talabostat mesylate) uniquely activates the CARD8 inflammasome, triggering pyroptotic cell death in resting human T cells. These findings expand the mechanistic understanding of T cell fate regulation and highlight the specificity of CARD8-mediated pathways in adaptive immunity.

• A23187, Free Acid: Precision Calcium Ionophore for Translati

  2026-07-14

  Explore how A23187, free acid, a leading calcium ionophore, enables translational researchers to dissect, manipulate, and translate calcium signaling mechanisms into actionable insights for cell death, viability, and metabolic assays. This article advances beyond standard product profiles by integrating mechanistic depth, evidence-based workflow guidance, and strategic recommendations for in vitro cancer research.

• IEM 1460: Translating AMPA Blockade into Neuroprotective Str

  2026-07-14

  This thought-leadership article explores the mechanistic foundation and translational promise of IEM 1460, a selective AMPA receptor blocker, for advancing neuroprotection and excitotoxicity research. Integrating recent breakthroughs in glutamate receptor targeting—including dual antagonist strategies against nerve agent-induced neurotoxicity—this piece provides actionable guidance for experimental design and outlines strategic opportunities for translational researchers seeking to leverage AMPA receptor inhibition.

• Safe DNA Gel Stain: Applied Workflows for Reliable Nucleic A

  2026-07-13

  Safe DNA Gel Stain streamlines DNA and RNA visualization with superior safety and sensitivity, making it a compelling choice for molecular biology workflows. Its compatibility with blue-light imaging and reduced mutagenicity directly boost cloning efficiency and lab safety standards.

• Drug Efficacy Against Azumiobodo hoyamushi in Soft Tunic Syn

  2026-07-13

  This study systematically evaluates the in vitro and in vivo effectiveness of diverse antiprotozoal agents, including Fumagillin, against Azumiobodo hoyamushi—the causative agent of soft tunic syndrome in Halocynthia roretzi. The findings identify promising disinfection strategies and position Fumagillin as a moderately potent candidate for parasite control in aquaculture.

• SR 11302: Precision AP-1 Transcription Factor Inhibitor in C

  2026-07-12

  SR 11302 redefines targeted cancer research by enabling highly selective AP-1 transcription factor inhibition, minimizing off-target retinoid effects. This guide delivers actionable protocols, troubleshooting strategies, and translational insights for advanced chemopreventive and therapeutic workflows.

• Strategic HSP70 Inhibition: VER 155008 for Translational Onc

  2026-07-10

  This thought-leadership article explores how VER 155008, a small-molecule HSP 70 inhibitor, empowers translational researchers to dissect and modulate chaperone-mediated oncogenic pathways. Integrating mechanistic insight, protocol optimization, and strategic translational guidance, it uniquely bridges molecular rationale, experimental validation, and the evolving clinical landscape—advancing beyond standard product summaries and existing applied workflows.

• Murine RNase Inhibitor: Optimizing RNA Integrity in RT-PCR W

  2026-07-09

  Murine RNase Inhibitor offers robust, oxidation-resistant RNA protection, elevating the reliability of sensitive assays like real-time RT-PCR and cDNA synthesis. This guide delivers practical protocols, troubleshooting strategies, and advanced use-cases grounded in the latest research and real-world laboratory experience.

• gamma-Glu-Cys (γ-Glu-Cys) in Glutathione Metabolism Workflow

  2026-07-09

  gamma-Glu-Cys (γ-Glu-Cys) provides researchers with a highly pure, workflow-compatible substrate for glutathione synthetase enzyme assays, thiol-reactive peptide synthesis, and plant stress adaptation studies. This product is not suitable for diagnostic or clinical applications and should not be used in protocols requiring long-term solution storage.

• Intestinal TM6SF2 Deficiency Drives MASH via Gut–Liver Axis

  2026-07-08

  This study uncovers a previously unrecognized protective function of intestinal TM6SF2 against metabolic dysfunction-associated steatohepatitis (MASH). By demonstrating the mechanistic link between TM6SF2, gut barrier integrity, microbiota composition, and hepatic inflammation via lysophosphatidic acid signaling, the work provides new targets for experimental modeling and intervention in metabolic liver disease.

• Optimizing Cell Assays with 3-Aminobenzamide (PARP-IN-1): SK

  2026-07-08

  This article delivers scenario-driven guidance for biomedical researchers leveraging 3-Aminobenzamide (PARP-IN-1) (SKU A4161) to overcome assay variability, optimize poly (ADP-ribose) polymerase inhibition, and ensure reproducibility in cell-based studies. By integrating current literature with practical protocol insights, we demonstrate how SKU A4161 from APExBIO stands out for its potency, data transparency, and workflow reliability across oxidative stress, endothelial function, and diabetic nephropathy research.

449 records 11/30 page Previous Next First page 上5页 1112131415 下5页 Last page